Quantcast

David Weinstein Appointed to Allele Fund Advisory Board

August 16, 2012

Allele funds are delighted to announce that David Weinstein has joined the Allele Funds Advisory Board. David Weinstein is a fellow at the Advanced Leadership Institute at Harvard University.

(PRWEB) August 16, 2012

Dr Gail Lese, who was previously a successful fund manager for a $100m Fidelity fund, and Cherie Blair, the distinguished international barrister, who together co-founded the Allele Fund (“Allele”) are delighted to announce that David Weinstein has joined the Allele Funds Advisory Board.

David Weinstein is a Fellow at the Advanced Leadership Institute at Harvard University. He chairs the Board of Overseers of Boston College Law School and serves as a trustee of Boston College and Belmont Hill School. He has taught classes on business and financial topics at BC Law and was vice-chairman of the board of Bryant University.

During his 24 year career as a senior business executive and corporate lawyer at Fidelity Investments, the largest mutual fund company in the United States, Mr. Weinstein was Chief of Administration, managing the company´s legal, human resources, real estate, compliance, security, audit, and accounting functions.

Commenting on David´s appointment, Dr Gail Lese, said: “I´m truly delighted that David has joined the Advisory Board of the Allele Funds. David has an unparalleled reputation in the financial services industry for his distinguished leadership. He brings a wealth of expertise and decades of experience to the Allele Funds. It is an honour and a pleasure to have him join us, and for him to work with us on behalf of our investors and all we are entrusted to serve.”

For further information, please contact:

Faeth Birch, RLM Finsbury at faeth(dot)birch(at)rlmfinsbury(dot)com or +44 7768 943171

Ed Lane Fox, RLM Finsbury at ed(dot)lanefox(at)rlmfinsbury(dot)com or +44 7733294930

For additional information on Allele and Mee Healthcare please go to http://www.allelefund.com or http://www.meehealthcare.com

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/8/prweb9798529.htm


Source: prweb



comments powered by Disqus